• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Pharmacokinetics of rocuronium bromide in patients with and without renal failure.

作者信息

Cooper R A, Mirakhur R K, Wierda J M, Maddineni V R

机构信息

Department of Anaesthetics, Queen's University of Belfast, UK.

出版信息

Eur J Anaesthesiol Suppl. 1995 Sep;11:43-4.

PMID:8557005
Abstract

We studied the onset and duration of action and pharmacokinetics of rocuronium bromide during anaesthesia with nitrous oxide, fentanyl and isoflurane after a single bolus dose of rocuronium (0.6 mg kg-1) in nine patients with chronic renal failure requiring regular haemodialysis, and in nine healthy control patients. Blood samples were collected over 390 min and concentrations of rocuronium and its putative metabolites measured using HPLC. Onset time for maximum block and duration of clinical relaxation (DUR25) were 61 (SD 25.0) s and 65 (16.4) s, 55 (26.9) min and 42 (9.3) min, respectively, for patients with and without renal failure. The time for train-of-four ratio to return spontaneously to 0.7 was 99 (41.1) min and 73 (24.2) min, respectively, in the two groups. None of these differences was significant. The pharmacokinetic data were best described by a three-exponential equation. There were significant differences between patients with and without renal failure in the rates of clearance (2.5 (1.1) mL kg-1 min-1 and 3.7 (1.4) mL kg-1 min-1, respectively) and the mean residence times (97.1 (48.7) min and 58.3 (9.6) min) (P < 0.05). The differences in other kinetic parameters were not significant.

摘要

相似文献

1
Pharmacokinetics of rocuronium bromide in patients with and without renal failure.
Eur J Anaesthesiol Suppl. 1995 Sep;11:43-4.
2
Time course of neuromuscular effects and pharmacokinetics of rocuronium bromide (Org 9426) during isoflurane anaesthesia in patients with and without renal failure.在有和没有肾衰竭的患者中,异氟烷麻醉期间罗库溴铵(Org 9426)的神经肌肉效应和药代动力学的时间过程。
Br J Anaesth. 1993 Aug;71(2):222-6. doi: 10.1093/bja/71.2.222.
3
Pharmacodynamics of rocuronium 0.3 mg kg(-1) in adult patients with and without renal failure.0.3毫克/千克罗库溴铵在有和没有肾衰竭的成年患者中的药效学
Eur J Anaesthesiol. 2005 Dec;22(12):929-32. doi: 10.1017/S0265021505001584.
4
Rocuronium pharmacokinetic-pharmacodynamic relationship under stable propofol or isoflurane anesthesia.在丙泊酚或异氟烷稳定麻醉下罗库溴铵的药代动力学-药效学关系
Can J Anaesth. 2002 Apr;49(4):353-60. doi: 10.1007/BF03017322.
5
Pharmacokinetic-pharmacodynamic relationship of rocuronium under stable nitrous oxide-fentanyl or nitrous oxide-sevoflurane anesthesia in children.在儿童中,氧化亚氮-芬太尼或氧化亚氮-七氟醚稳定麻醉下罗库溴铵的药代动力学-药效学关系。
Paediatr Anaesth. 2006 Jul;16(7):761-8. doi: 10.1111/j.1460-9592.2005.01840.x.
6
Time-course of action and intubating conditions with rocuronium bromide under propofol-alfentanil anaesthesia.在丙泊酚-阿芬太尼麻醉下使用罗库溴铵的作用时效及插管条件
Eur J Anaesthesiol Suppl. 1995 Sep;11:69-72.
7
Onset and duration of action and hemodynamic effects of rocuronium bromide under balanced and volatile anesthesia.平衡麻醉和挥发性麻醉下罗库溴铵的起效时间、作用持续时间及血流动力学效应
Acta Anaesthesiol Belg. 1994;45(2):41-7.
8
Neuromuscular recovery following rocuronium bromide single dose in infants.婴儿单次注射罗库溴铵后的神经肌肉恢复情况。
Paediatr Anaesth. 2004 Apr;14(4):329-35. doi: 10.1046/j.1460-9592.2003.01216.x.
9
Sevoflurane increases fade of neuromuscular response to TOF stimulation following rocuronium administration in children. A PK/PD analysis.七氟醚会增加儿童使用罗库溴铵后对强直刺激后单爆发刺激(TOF)的神经肌肉反应衰减。一项药代动力学/药效学分析。
Paediatr Anaesth. 2007 Jul;17(7):637-46. doi: 10.1111/j.1460-9592.2006.02181.x.
10
The effect of isoflurane versus balanced anesthesia on rocuronium's pharmacokinetics and infusion requirement.异氟烷与平衡麻醉对罗库溴铵药代动力学及输注需求的影响。
Pharmacotherapy. 1995 Jan-Feb;15(1):36-41.

引用本文的文献

1
Newer neuromuscular blocking agents: how do they compare with established agents?新型神经肌肉阻滞剂:与现有药物相比如何?
Drugs. 2001;61(7):919-42. doi: 10.2165/00003495-200161070-00003.